• SENSEX
    NIFTY 50
India's March factory activity growth at four-month low
Demand slump: World food prices drop
Yellow metal gets costlier by Rs 500 per 10 grams
Rupee trades 51 paise lower at 76.06/USD
Home Market Stocks
Market

Aurobindo Pharma surges over 18% on receiving EIR from USFDA

Updated : February 19, 2020 11:46 AM IST

At 11:42 am, Aurobindo Pharma was trading 18.57 percent higher at Rs 593.10 per share.
Aurobindo Pharma surges over 18% on receiving EIR from USFDA

You May Also Like

Coronavirus: India needs to spend the emergency funds directly on health, says World Bank’s Junaid Kamal Ahmad

Coronavirus: India needs to spend the emergency funds directly on health, says World Bank’s Junaid Kamal Ahmad

NDTV 1 vs Taxman 0: SC quashes I-T plea on reopening accounts, alleging sham transactions worth Rs 1, 127 crore

NDTV 1 vs Taxman 0: SC quashes I-T plea on reopening accounts, alleging sham transactions worth Rs 1, 127 crore

Closing Bell: Sensex, Nifty end 2% lower as global coronavirus cases cross 1 million

Closing Bell: Sensex, Nifty end 2% lower as global coronavirus cases cross 1 million

Trending on CNBC-TV18

Live TV
Advertisement